Hanmi claims HM17321 is a 'game-changer' in overcoming GLP-1-associated muscle loss
Hanmi Pharm has announced promising research results for its novel obesity treatment, HM17321. According to the company, this...
top of page
Browse by category
Search
Poor muscle health common in people living with obesity increases early mortality risk
Poor muscle health is associated with a higher risk of an early death in people living with obesity and individuals with adverse muscle...
BELIEVE study to assess Bimagrumab as treatment for obesity
Versanis Bio, a clinical-stage biopharmaceutical company advancing novel therapeutics for cardiometabolic diseases, has announced that...
Browse by tag
bottom of page